DHA-EE withheld from Matthew August 2003
From Dr. Dwight Koeberl (Duke University) letter 9/29/2003
Recently, Matthew was not able to receive the DHA-EE for 4 weeks due to shipping problems during which parents substituted ‘Neuromins’ for him. He experienced the following symptoms: weight loss of 4.5 pounds, increased ataxia and hypotonia evidenced as losing his ability to walk/balance, lethargy, lack of interest in eating, irritability, seizures upon waking, and decrease in ability to concentrate and perform at school. After a week of re-introducing the DHA-EE from Spain, these symptoms have disappeared.
Parents also noted that Matthew stools started floating during this period of time, and this resolved quickly after the DHA-EE treatment resumed.